Cytochrome c and Apoptosis
Cytochrome c and Apoptosis
批准号:
0109366
负责人:
Gary Pielak
金额:
$10.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2003-08-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytochrome c and apoptosis activating factor-1 (apaf-1) are the judge andjury of mitochondrially-mediated programmed cell death (apoptosis). Theirinteraction seals a cell's fate by launching a tightly controlled program that endsin cellular disintegration, and imbalances in this regulation are associated withcancer, neurological diseases, and heart disease. Given the biological andmedical relevance of this protein-protein reaction, it is surprising that itsmolecular basis is unknown. The broad long-term goal of this project is todetermine the molecular basis for the interaction between cytochrome c andapaf-1. The main hypotheses are: a) Cytochrome c uses the same cationicpatch to interact with apaf-1 and its redox partners. b) Apaf-1 uses specificanionic patches to interact with cytochrome c.The specific aims are 1) Quantify apaf-1 / cytochrome c binding, 2) Identifyprobable binding sites on apaf-1 and cytochrome c, 3) Test the binding sites.Sedimentation equilibrium methods will be used to quantify binding, butalternative methods are also discussed. Probable binding sites on the WD repeatdomain of apaf-1 have been identified in modeling studies, and the redox-partnerbinding site on cytochrome c has been known for many years. The siteswill be tested by using site directed mutagenesis. To ensure that biologicallysignificant data are obtained, the variants will first be assessed by using a quickand biologically relevant caspase activation assay. Once the biologicallyrelevant residues have been identified, the biophysics of the variants will becharacterized. Circular dichroism spectropolarimetry will be used to assess theirintegrity. Sedimentation velocity experiments on apaf-1 variants will be used toassess their effects on intraprotein interactions. Sedimentation equilibriumtechniques from aim 1 will be used to quantify their effects on the free energyand stoichiometry of complex formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF-BSF: Macromolecular crowding in vitro and in cells
-
批准号:2335137
-
项目类别:Standard Grant
-
资助金额:$75.0万
-
财政年份:2024
-
负责人:Gary Pielak
-
依托单位:
Mechanisms of Protein Protection by Desiccation-tolerance Molecules
-
批准号:2203505
-
项目类别:Continuing Grant
-
资助金额:$49.5万
-
财政年份:2022
-
负责人:Gary Pielak
-
依托单位:
Macromolecular crowding in vitro and in cells
-
批准号:1909664
-
项目类别:Standard Grant
-
资助金额:$90.0万
-
财政年份:2019
-
负责人:Gary Pielak
-
依托单位:
Encapsulation and Protein Stability
-
批准号:1607359
-
项目类别:Standard Grant
-
资助金额:$35.39万
-
财政年份:2016
-
负责人:Gary Pielak
-
依托单位:
Macromolecular crowding in vitro and in cells
-
批准号:1410854
-
项目类别:Continuing Grant
-
资助金额:$121.94万
-
财政年份:2014
-
负责人:Gary Pielak
-
依托单位:
Protein Biophysics in Cells
-
批准号:0516547
-
项目类别:Continuing Grant
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Gary Pielak
-
依托单位:
Protein Biophysics in Cells
-
批准号:0212939
-
项目类别:Continuing Grant
-
资助金额:$44.67万
-
财政年份:2002
-
负责人:Gary Pielak
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: